These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 24340510

  • 1. The role of rifaximine in the prevention of the spontaneous bacterial peritonitis.
    Dănulescu RM, Ciobică A, Stanciu C, Trifan A.
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):315-20. PubMed ID: 24340510
    [Abstract] [Full Text] [Related]

  • 2. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A, Abo Ali L, Soliman S, Ibrahim S, Abd-Elsalam S.
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM, Stanciu C, Trifan A.
    Rev Med Chir Soc Med Nat Iasi; 2014 Dec; 118(2):320-6. PubMed ID: 25076694
    [Abstract] [Full Text] [Related]

  • 8. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
    [Abstract] [Full Text] [Related]

  • 9. [Spontaneous bacterial peritonitis].
    Skladaný Ľ, Kasová S, Purgelová A, Bystrianska N, Adamcová-Selčanová S.
    Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.
    Oliver A, Wong M, Sanchez C.
    South Med J; 2018 Nov; 111(11):660-665. PubMed ID: 30392000
    [Abstract] [Full Text] [Related]

  • 13. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis.
    Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK.
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1109-1117. PubMed ID: 28763340
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
    Goel A, Rahim U, Nguyen LH, Stave C, Nguyen MH.
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1029-1036. PubMed ID: 28994123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial.
    Praharaj DL, Premkumar M, Roy A, Verma N, Taneja S, Duseja A, Dhiman RK.
    J Clin Exp Hepatol; 2022 Dec; 12(2):336-342. PubMed ID: 35535057
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.